Enhanced expression of tissue inhibitor of metalloproteinases-4 gene in human osteoarthritic synovial membranes and its differential regulation by cytokines in chondrocytes

Open Rheumatology Journal

Volumn 5, Issue 1, 2011, Pages 81-87

  Huang, Wensheng ^a   El Mabrouk, Mohammed ^a   Sylvester, Judith ^a   Dehnade, Faramaze ^a   Zafarullah, Muhammad ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

Chondrocytes; Cytokines; Osteoarthritis; Synovium; TIMP 4

Indexed keywords

CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 1BETA; MESSENGER RNA; ONCOSTATIN M; RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARTILAGE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; FEMUR HEAD; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KNEE OSTEOARTHRITIS; KNEE SURGERY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SYNOVIUM; UPREGULATION; WESTERN BLOTTING;

EID: 84862913236     PISSN: None     EISSN: 18743129     Source Type: Journal    
DOI: 10.2174/1874312901105010081     Document Type: Article

References (28)

1. Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 2002; 115: 3719-27.
2. Fernandez CA, Moses MA. Modulation of angiogenesis by tissue inhibitor of metalloproteinase-4. Biochem Biophys Res Commun 2006; 345: 523-9.
3. Mohammed FF, Smookler DS, Khokha R. Metalloproteinases, inflammation, and rheumatoid arthritis. Ann Rheum Dis 2003; 62(Suppl 2): ii43-7.
4. van der Laan WH, Quax PH, Seemayer CA, et al. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3. Gene Ther 2003; 10: 234-42.
5. Greene J, Wang M, Liu YE, et al. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996; 271: 30375-80.
6. Stratmann B, Farr M, Tschesche H. Characterization of Cterminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris. Biol Chem 2001; 382: 987-91.
7. English JL, Kassiri Z, Koskivirta I, et al. Individual timp deficiencies differentially impact pro-MMP-2 activation. J Biol Chem 2006; 281: 10337-46.
8. Su S, Grover J, Roughley PJ, et al. Expression of the tissue inhibitor of metalloproteinases (TIMP) gene family in normal and osteoarthritic joints. Rheumatol Int 1999; 18: 183-91.
9. Celiker MY, Ramamurthy N, Xu JW, et al. Inhibition of adjuvantinduced arthritis by systemic tissue inhibitor of metalloproteinases 4 gene delivery. Arthritis Rheum 2002; 46: 3361-8.
10. Ramamurthy NS, Greenwald RA, Celiker MY, Shi EY. Experimental arthritis in rats induces biomarkers of periodontitis which are ameliorated by gene therapy with tissue inhibitor of matrix metalloproteinases. J Periodontol 2005; 76: 229-33.
11. Aicher WK, Alexander D, Haas C, et al. Transcription factor early growth response 1 activity up-regulates expression of tissue inhibitor of metalloproteinases 1 in human synovial fibroblasts. Arthritis Rheum 2003; 48: 348-59.
12. Huang W, Li WQ, Dehnade F, Zafarullah M. Tissue inhibitor of metalloproteinases-4 (TIMP-4) gene expression is increased in human osteoarthritic femoral head cartilage. J Cell Biochem 2002; 85: 295-303.
13. Huber LC, Distler O, Tarner I, et al. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 2006; 45: 669-75.
14. Mor A, Abramson SB, Pillinger MH. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol 2005; 115: 118-28.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
16. Goldring SR, Goldring MB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 2004; 427(Suppl): S27-S36.
17. Qureshi HY, Sylvester J, El Mabrouk M, Zafarullah M. TGF-betainduced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor. J Cell Physiol 2005; 203: 345-52.
18. Yuan GH, Tanaka M, Masuko-Hongo K, et al. Characterization of cells from pannus-like tissue over articular cartilage of advanced osteoarthritis. Osteoarthr Cartil 2004; 12: 38-45.
19. Saito I, Koshino T, Nakashima K, Uesugi M, Saito T. Increased cellular infiltrate in inflammatory synovia of osteoarthritic knees. Osteoarthr Cartil 2002; 10: 156-62.
20. Koskivirta I, Rahkonen O, Mayranpaa M, et al. Tissue inhibitor of metalloproteinases 4 (TIMP4) is involved in inflammatory processes of human cardiovascular pathology. Histochem Cell Biol 2006; 126: 335-42.
21. Jiang Y, Wang M, Celiker MY, et al. Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery. Cancer Res 2001; 61: 2365-70.
22. Kevorkian L, Young DA, Darrah C, et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 2004; 50: 131-41.
23. Sasaki K, Takagi M, Mandelin J, et al. Quantitative analysis of mRNA expression of TIMPs in the periprosthetic interface tissue of loose hips by real-time PCR system. J Biomed Mater Res 2001; 58: 605-12.
24. Reno C, Boykiw R, Martinez ML, Hart DA. Temporal alterations in mRNA levels for proteinases and inhibitors and their potential regulators in the healing medial collateral ligament. Biochem Biophys Res Commun 1998; 252: 757-63.
25. Lee HJ, Lee GH, Nah S, et al. Association of TIMP-4 gene polymorphism with the risk of osteoarthritis in the Korean population. Rheumatol Int 2008; 28: 845-50.
26. Kawakami A, Urayama S, Yamasaki S, et al. Anti-apoptogenic function of TGFbeta1 for human synovial cells: TGFbeta1 protects cultured synovial cells from mitochondrial perturbation induced by several apoptogenic stimuli. Ann Rheum Dis 2004; 63: 95-7.
27. Li WQ, Zafarullah M. Oncostatin M up-regulates tissue inhibitor of metalloproteinases-3 gene expression in articular chondrocytes via de novo transcription, protein synthesis, and tyrosine kinase-and mitogen-activated protein kinase-dependent mechanisms. J Immunol 1998; 161: 5000-7.
28. Murphy G, Lee MH. What are the roles of metalloproteinases in cartilage and bone damage? Ann Rheum Dis 2005; 64(Suppl 4): iv44-7.